Unleashing the Power of Low Dose Naltrexone: A Game-Changer for Hashimoto's & Autoimmune Disorders

As a thyroid expert, I have coached hundreds of people all over the world. Many of my Hashimoto's clients have benefitted from the incredible benefits of low-dose naltrexone (LDN).

LDN is a medication that was originally approved for the treatment of addiction and opioid dependence but has since been discovered to have a wide range of therapeutic benefits, from reducing inflammation and pain to improving mood and immune function. LDN works by increasing the production of endorphins, our body's natural painkillers and mood boosters. It also modulates the immune system, leading to a reduction in inflammation and a strengthened response to infection and disease.

What's truly remarkable about LDN is its ability to treat a wide range of health issues, including autoimmune disorders like Hashimoto’s Disease, chronic pain, depression, and even certain types of cancer. And best of all, it's well-tolerated with very few side effects, making it a safe and natural alternative to many prescription drugs.

Don’t just take my word for it. There's a growing body of research supporting the use of LDN for a variety of health conditions. A recent study published in the journal Pain Medicine found that LDN was effective in reducing chronic pain in patients with fibromyalgia, a debilitating condition that affects millions of people.

Low-dose naltrexone (LDN) has been studied for its potential effect on reducing antibodies in Hashimoto's thyroiditis, an autoimmune disease that affects the thyroid gland. I have seen this firsthand with my coaching: One client kept a perfect AIP diet (autoimmune protocol) and after a year, her Hashimoto’s antibodies were not budging. After just 3 months of using LDN, her antibody levels dropped by 50%. And that is just one of many success stories that I have witnessed.

In a study published in the Autoimmunity Reviews journal, researchers found that LDN decreased thyroid peroxidase (TPO) antibodies in a group of patients with Hashimoto's thyroiditis. The study suggested that LDN may have immunomodulatory effects that reduce autoimmune activity in patients with Hashimoto's.

Another study published in the Journal of Autoimmunity also showed promising results for LDN in reducing TPO antibodies in patients with Hashimoto's. The study found that after three months of treatment with LDN, the average TPO antibody levels decreased significantly.

LDN doses often range from .5 mg or 1 mg up to 5 or 6 mgs per day. Just be sure to work with a healthcare practitioner to determine the right dose for your specific needs.

About the author:  Elle Russ is a #1 bestselling author, world-renowned thyroid health expert, and master coach.Take her Thyroid Masterclass HERE  

Listen to a podcast episode about LDN with Elle Russ and Functional Medicine physician Dr. Gary E. Foresman, M.D. - you can listen to that HERE